BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 2019; 25(33): 4814-4834 [PMID: 31543676 DOI: 10.3748/wjg.v25.i33.4814]
URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4814.htm
(356) (342) (0) (0) (16485) (149)
Number Citing Articles
1
Célia Chamignon, Geoffroy Mallaret, Julie Rivière, Marthe Vilotte, Sead Chadi, Alejandra de Moreno de LeBlanc, Jean Guy LeBlanc, Frédéric Antonio Carvalho, Marco Pane, Pierre-Yves Mousset, Philippe Langella, Sophie Lafay, Luis G. Bermúdez-Humarán. Beneficial Effects of Lactobacilli Species on Intestinal Homeostasis in Low-Grade Inflammation and Stress Rodent Models and Their Implication in the Modulation of the Adhesive Junctional Complex. Biomolecules 2023; 13(9) doi: 10.3390/biom13091295
2
Ali Riza Caliskan, Mehmet Gul, Ismet Yılmaz, Baris Otlu, Nuray Uremis, Muhammed Mehdi Uremis, Ilkay Kilicaslan, Semir Gul, Deniz Tikici, Osman Saglam, Muhammed Yalcin, Ulvi Demirel, Murat Harputluoglu. Effects of larazotide acetate, a tight junction regulator, on the liver and intestinal damage in acute liver failure in rats. Human & Experimental Toxicology 2021; 40(12_suppl) doi: 10.1177/09603271211058882
3
Yi Yuan, Xiyang Wang, Shun Huang, Hao Wang, Guoming Shen. Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2263209
4
Dmitry Victorovich Garbuzenko. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World Journal of Clinical Cases 2022; 10(12): 3662-3676 doi: 10.12998/wjcc.v10.i12.3662
5
Jiahao Huang, Xinbo Sun, Yang Wang, Jianlong Su, Guangzhe Li, Xu Wang, Yuning Yang, Yuxuan Zhang, Bangjian Li, Guanyi Zhang, Jinrong Li, Jing Du, Roopa Hebbandi Nanjundappa, Channakeshava Sokke Umeshappa, Kun Shao. Biological interactions of polystyrene nanoplastics: Their cytotoxic and immunotoxic effects on the hepatic and enteric systems. Ecotoxicology and Environmental Safety 2023; 264 doi: 10.1016/j.ecoenv.2023.115447
6
Jong Hwan Sung, Raehyun Kim. In vitro models of the gut-liver axis: what we’ve learned and what remains to be built. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1858289
7
Yiwei Dong, Qianqian Cai, Lisheng Fu, Haojie Liu, Mingzhe Ma, Xingzhong Wu, Tao Huang. Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/4873678
8
Pavlo Petakh, Valentyn Oksenych, Iryna Kamyshna, Iryna Boisak, Katerina Lyubomirskaya, Oleksandr Kamyshnyi. Exploring the complex interplay: gut microbiome, stress, and leptospirosis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1345684
9
Victor Sánchez, Annette Brandt, Cheng Jun Jin, Dragana Rajcic, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance. Nutrients 2021; 13(3) doi: 10.3390/nu13030959
10
Silvia Lopez-Escalera, Mari L. Lund, Gerben D. A. Hermes, Béatrice S.-Y. Choi, Kei Sakamoto, Anja Wellejus. In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention. Nutrients 2023; 15(10) doi: 10.3390/nu15102361
11
Aswathi Ramesh, Rajasekaran Subbarayan, Dhasarathdev Srinivasan, Ranjith Balakrishnan, Rupendra Shrestha, Ankush Chauhan. Gut microbiota-mediated oncogenesis in hepatocellular carcinoma: a new avenue for therapeutic intervention. International Journal of Surgery 2026; 112(2) doi: 10.1097/JS9.0000000000003851
12
Alessio Ardizzone, Marika Lanza, Giovanna Casili, Michela Campolo, Irene Paterniti, Salvatore Cuzzocrea, Emanuela Esposito. Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion. Nutrients 2022; 14(11) doi: 10.3390/nu14112251
13
Fiorella D’Onofrio, Giorgia Renga, Matteo Puccetti, Marilena Pariano, Marina Maria Bellet, Ilaria Santarelli, Claudia Stincardini, Paolo Mosci, Maurizio Ricci, Stefano Giovagnoli, Claudio Costantini, Luigina Romani. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis. Cells 2021; 10(7) doi: 10.3390/cells10071622
14
Xu Zhang, Jing Chen, Shengmin Zhou, Yuanrong Jiang, Yong Wang, Ying Li. The effect of flaxseed oil after deep frying on lipid metabolism and gut barrier homeostasis. Food Research International 2024; 175 doi: 10.1016/j.foodres.2023.113728
15
Maria Cerreto, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Ponziani. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis. Nutrients 2021; 13(8) doi: 10.3390/nu13082649
16
Doyeon Kim, Sangbin Han, Ju Dong Yang, Ji-Hye Kwon, Gyu-Sung Choi, Jong Man Kim, Yoon Joo Chung, Chisong Chung, Justin S. Ko, Mi Sook Gwak, Jae-Won Joh, Gaab Soo Kim. Bacterial contamination of autologous blood salvaged during deceased donor liver transplantation: a prospective observational study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-76476-w
17
Tamilmani Periyasamy, V. V. Sathibabu Uddandrao, Chandrasekaran Ponnusamy, Saravanan Ganapathy, Sethumathi Ponnusamy Pudhupalayam, Sengottuvelu Singaravel, Ponmurugan Ponnusamy, Jagadeesan Ramasamy, Kalaivani Aiyasamy, Vadivukkarasi Sasikumar. Linalool Mitigated High-Fat Diet–Induced Non-alcoholic Fatty Liver Disease by Regulating the Intestinal-Hepatic Axis via TGF-β/NF-kB/TLR4/ZO-1 Pathway. Revista Brasileira de Farmacognosia 2023; 33(3) doi: 10.1007/s43450-023-00395-6
18
Mariana M. Ramírez-Mejía, Guadalupe Ponciano-Rodríguez, Nahum Méndez-Sánchez. Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets. Archives of Medical Research 2025; 56(8) doi: 10.1016/j.arcmed.2025.103335
19
Yang Ye, Yanan Liu, Kejun Cheng, Zufang Wu, Peng Zhang, Xin Zhang. Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.810453
20
Jin-Chun Liu, Ji-Shuai Wang. Intestinal microbiota in the treatment of metabolically associated fatty liver disease. World Journal of Clinical Cases 2022; 10(31): 11240-11251 doi: 10.12998/wjcc.v10.i31.11240
21
Mohamad Jamalinia, Fatemeh Zare, Amedeo Lonardo. Liver Fibrosis and Risk of Incident Dementia in the General Population: Systematic Review With Meta‐Analysis. Health Science Reports 2025; 8(11) doi: 10.1002/hsr2.71530
22
Akira Sakamaki, Kunihiko Yokoyama, Hanako Yamazaki, Takuya Wakabayashi, Yuichi Kojima, Kentaro Tominaga, Atsunori Tsuchiya, Kenya Kamimura, Junji Yokoyama, Shuji Terai. Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis. Journal of Clinical Medicine 2025; 14(5) doi: 10.3390/jcm14051491
23
Mihaela Stoyanova, Vera Gledacheva, Stoyanka Nikolova. Gut–Brain–Microbiota Axis in Irritable Bowel Syndrome: A Narrative Review of Pathophysiology and Current Approaches. Applied Sciences 2025; 15(12) doi: 10.3390/app15126441
24
Andrei Dumitru, Elena Matei, Georgeta Camelia Cozaru, Anca Chisoi, Luana Alexandrescu, Răzvan Cătălin Popescu, Mihaela Pundiche Butcaru, Eugen Dumitru, Sorin Rugină, Cristina Tocia. Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut–Liver Axis. International Journal of Molecular Sciences 2024; 25(5) doi: 10.3390/ijms25052472
25
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Maria Zharkova, Oxana Zolnikova, Gyunay Bagieva, Vladimir Ivashkin. Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis. World Journal of Hepatology 2024; 16(5): 822-831 doi: 10.4254/wjh.v16.i5.822
26
Luca Miele, Maria Adele Alberelli, Maurizio Martini, Antonio Liguori, Giuseppe Marrone, Alessandra Cocomazzi, Fabio Maria Vecchio, Raffaele Landolfi, Antonio Gasbarrini, Antonio Grieco, Erica De Candia. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets. Translational Research 2021; 231 doi: 10.1016/j.trsl.2020.11.003
27
D. V. Garbuzenko. Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis. The Russian Archives of Internal Medicine 2022; 12(5) doi: 10.20514/2226-6704-2022-12-5-352-362
28
Nethravathy Malachira Uthaiah, Sreedhar Reddampalli Venkataramareddy, Seema Mudhol, Azam Yakub Sheikh. EPA-rich Nannochloropsis oceanica biomass regulates gut microbiota, alleviates inflammation and ameliorates liver fibrosis in rats. Food Research International 2025; 202 doi: 10.1016/j.foodres.2025.115733
29
Xiling Wang, Bing Zheng, Xianxiang Chen, Yi Chen, Jianhua Xie, Jiajun Song, Xingcai Gao, Qiang Yu. Polygonatum cyrtonema Hua mitigates DSS-induced ulcerative colitis more effectively with specific steaming and basking cycles. Industrial Crops and Products 2026; 239 doi: 10.1016/j.indcrop.2025.122571
30
Indira Bhavsar‐Burke, Claire L. Jansson‐Knodell, Ashley C. Gilmore, David W. Crabb. Review article: the role of nutrition in alcohol‐associated liver disease. Alimentary Pharmacology & Therapeutics 2021; 53(12) doi: 10.1111/apt.16380
31
Federica Riva, Susanna Draghi, Alessia Inglesi, Joel Filipe, Paola Cremonesi, Antonio Lavazza, Patrizia Cavadini, Daniele Vigo, Stella Agradi, Laura Menchetti, Alessia Di Giancamillo, Lucia Aidos, Silvia Clotilde Modina, Nour Elhouda Fehri, Grazia Pastorelli, Valentina Serra, Claudia Maria Balzaretti, Marta Castrica, Marco Severgnini, Gabriele Brecchia, Giulio Curone. Bovine Colostrum Supplementation in Rabbit Diet Modulates Gene Expression of Cytokines, Gut–Vascular Barrier, and Red-Ox-Related Molecules in the Gut Wall. Animals 2024; 14(5) doi: 10.3390/ani14050800
32
Maria Consiglia Bragazzi, Rosanna Venere, Anthony Vignone, Domenico Alvaro, Vincenzo Cardinale. Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence. International Journal of Molecular Sciences 2023; 24(7) doi: 10.3390/ijms24076660
33
Qingxue Chen, Liu Yang, Fangqin Xiang, Ignatius Man-Yau Szeto, Yalu Yan, Biao Liu, Jinju Cheng, Lu Liu, Bailiang Li, Sufang Duan. 2’-Fucosyllactose modulates the function of intestinal microbiota to reduce intestinal permeability in mice colonized by feces from healthy infants. Food Science and Human Wellness 2025; 14(1) doi: 10.26599/FSHW.2024.9250021
34
I.A. Yatskov, V.A. Beloglazov, E.S. Ageeva, I.N. Repinskaya, D.I. Ulyanova. Experience of using mineral waters in patients with type 1 diabetes mellitus for the correction of endotoxinemia. Problems of Balneology, Physiotherapy and Exercise Therapy 2025; 102(6) doi: 10.17116/kurort202510206126
35
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher. The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021; 10(11) doi: 10.3390/cells10112959
36
Fan Li, Meng-Yue Zhang, Xiao-Le Shan, Cai-Yun Wang, Ying-Ying Wu, Shuang Li, Shi-Qiao Xu, Yi-Xuan Zhang. An Orally Deliverable, Food-Compatible Lyophilized Recombinant Whole-Cell Catalyst for Alcohol-Associated Liver Injury. Microorganisms 2026; 14(4) doi: 10.3390/microorganisms14040746
37
Khadija A.M. Glal, Sahar M. El-Haggar, Sherief M. Abdel-Salam, Tarek M. Mostafa. Allopurinol Prevents Cirrhosis-Related Complications: A Quadruple Blind Placebo-Controlled Trial. The American Journal of Medicine 2024; 137(1) doi: 10.1016/j.amjmed.2023.09.016
38
Changrui Long, Xiaoyan Zhou, Fan Xia, Benjie Zhou. Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations. Biology 2024; 13(4) doi: 10.3390/biology13040243
39
Dorna Hashemi, Mohammad Vahedi Fard, Kimia Mohammadhasani, Mehdi Barati, Elyas Nattagh‐Eshtivani. Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review. Food Science & Nutrition 2025; 13(3) doi: 10.1002/fsn3.70092
40
Anatoli M. Pershko, I. I. Yarovenko, V. A. Pershko. Metabolic basis for substantiation of nutrition therapy in chronic liver diseases. Experimental and Clinical Gastroenterology 2022; (7) doi: 10.31146/1682-8658-ecg-203-7-185-191
41
Yu‑Cheng Chin, Chih-Chia Huang, I-Ling Hsu, Wan-Hua Tsai, Chia-Hsuan Chou, Yi‑Ting Fang, Jian‑Jia Su, Yao-Tsung Yeh, Hui-Yun Tsai, Cheng-Hsieh Huang, Szu-Wei Huang. Lactobacillus protects against lead-induced hepatotoxicity by preserving the gut barrier and microbiota remodeling. BMC Microbiology 2026; 26(1) doi: 10.1186/s12866-026-04956-2
42
Jiawei Ling, Ziwei Han, Junjie Qiu, Boyu Li, Dan Chen, Yongbo Wang, Jie Liu, Renhu Li, Dongchen Xu, Xuesong Liu, Yong Chen, Jinghui Zhang, Tengfei Xu. Dendrobium polysaccharides ameliorate alcohol-induced liver injury by inhibiting the pathogenic ER stress-sphingolipid axis. Phytomedicine 2026; 152 doi: 10.1016/j.phymed.2026.157863
43
Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis. Life 2023; 13(4) doi: 10.3390/life13040991
44
Raz Abdulqadir, Jessica Engers, Rana Al-Sadi. Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives. Current Developments in Nutrition 2023; 7(12) doi: 10.1016/j.cdnut.2023.102026
45
Zhuo Huang, Qinyan Yao, Shuang Ma, Jinjie Zhou, Xiaoxuan Wang, Qingguo Meng, Yaxin Liu, Zihan Yu, Xin Chen. The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1504395
46
Giulia Gibiino, Alessandro Sartini, Stefano Gitto, Cecilia Binda, Monica Sbrancia, Chiara Coluccio, Vittorio Sambri, Carlo Fabbri. The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(8) doi: 10.3390/nu13082772
47
Manvi Sharma, Itika Arora, Trygve O. Tollefsbol. Comprehensive Gut Microbiota. 2022;  doi: 10.1016/B978-0-12-819265-8.00007-3
48
Tin Ei Cho, Ying Meng, Guoying Zhang, Jianya Ling. Cordyceps‐Fermented Chinese Jujube Ameliorates Oxidative Stress and Restores Gut Microbiome in Alcohol‐Induced Liver Injury in Mice. Molecular Nutrition & Food Research 2025; 69(22) doi: 10.1002/mnfr.70243
49
Sathish Kumar Perumal, Madan Kumar Arumugam, Natalia A. Osna, Karuna Rasineni, Kusum K. Kharbanda. Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1478542
50
András Zóka, Béla Kádár, Eszter Vad. Fertőzésekhez kapcsolódó immunológiai jelenségek: a szürkezóna jelentősége. Orvosi Hetilap 2021; 162(38) doi: 10.1556/650.2021.32222
51
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Lorraine J. Gudas. Retinoids in the Pathogenesis and Treatment of Liver Diseases. Nutrients 2022; 14(7) doi: 10.3390/nu14071456
52
Zhiyang Tian, Changhui Li. The role of gut microbiota in the onset and development of sepsis and its therapeutic potential: mechanisms and research progress. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1718549
53
Maria-Emanuela Maxan, Frédéric Moens, Massimo Marzorati, Merianne Mohamad, Christine Yue, Jawal Said, Abdul W. Basit, Simon Gaisford, Vishal C. Patel. A multi-strain probiotic modulates gut microbiome composition, intestinal barrier integrity and inflammation in a multi-compartmental in vitro gut model of decompensated advanced chronic liver disease. International Journal of Pharmaceutics 2026; 693 doi: 10.1016/j.ijpharm.2026.126678
54
Ahmed Mohamed ElGhandour, Essam Mohammed Bayoumy, Moataz Mohammed Sayed, Moheb Sharaby Eskandaros, Abdelmomen Momen Mohamed Emam, Nahla Mohamed Teama, Manal Sabry Mohamed, Sonya Ahmed El-Gaaly. Value of zonulin as a diagnostic and prognostic marker in different degrees of nonalcoholic fatty liver disease. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00351-6
55
Yin Zhu, Xiaozhi Wang, Lujian Zhu, Yulu Tu, Wanting Chen, Lingwen Gong, Tongtong Pan, Hongwei Lin, Jing Lin, Huiling Sun, Yuli Ge, Li Wei, Yu Guo, Caide Lu, Yongping Chen, Lanman Xu. Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells. Toxicology and Applied Pharmacology 2022; 439 doi: 10.1016/j.taap.2022.115923
56
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
57
S. N. Mekhtiyev, O. A. Mekhtiyeva, O. M. Berko, A. M. Kolodkin. Role of increased intestinal permeability in the development and progression of liver diseases. Experimental and Clinical Gastroenterology 2023; (12) doi: 10.31146/1682-8658-ecg-220-12-130-139
58
Maria Victoria Fernandez-Cantos, Diego Garcia-Morena, Valeria Iannone, Hani El-Nezami, Marjukka Kolehmainen, Oscar P. Kuipers. Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD. Tissue Barriers 2021; 9(3) doi: 10.1080/21688370.2021.1879719
59
Lijun Xue, Kaimin Li, Yanfei Jia, Dongxue Yao, Xuexing Guo, Shuhong Zhang. Impact of High-Temperature Feeds on Gut Microbiota and MAFLD. Journal of Microbiology and Biotechnology 2024; 34(9) doi: 10.4014/jmb.2405.05023
60
Doina Georgescu, Oana-Elena Ancusa, Daniel Azoulay, Ana Lascu, Ioana Ionita, Despina Calamar-Popovici, Mihai Ionita, Ciprian Ilie Rosca, Gelu-Mihai Brează, Daniela Reisz, Daniel Lighezan. Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?. International Journal of General Medicine 2023;  doi: 10.2147/IJGM.S413438
61
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, Bobae Kim, Chang-Kee Hyun. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84761-1
62
Xuehua An, Ruike Wang, Chong Cao, Dou Wang, Chen Chen, Yanhua Wang. Synergistic risk in the gut and liver: Insights into the toxic mechanisms and molecular interactions of combined exposure to triazophos and fenvalerate in zebrafish. Science of The Total Environment 2024; 948 doi: 10.1016/j.scitotenv.2024.174710
63
Kexin Tao, Han Peng, Xin Bi, Xiaoya Wang, Yue Tian, Hua Zhang, Yong Sun. Effect of Tetrastigma hemsleyanum leaves and Extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injury. Food Bioscience 2024; 58 doi: 10.1016/j.fbio.2024.103617
64
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Abdulsalam Najm Mohammed, Jitendra Gupta, Jaafaru Sani Mohammed, R. Roopashree, Aditya Kashyap, Bethanney Janney J, Samir Sahoo, Shaker Al-Hasnaawei, Yassir Mohammed Nasr. Combating oxidative stress in non-alcoholic fatty liver disease: From mechanisms to therapeutic strategies. Pathology - Research and Practice 2025; 272 doi: 10.1016/j.prp.2025.156053
65
Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno. Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. The Journal of Nutritional Biochemistry 2020; 85 doi: 10.1016/j.jnutbio.2020.108478
66
A. S. Ostrovskaya, M. V. Maevskaya. Sarcopenia and malnutrition in patients with liver diseases. Meditsinskiy sovet = Medical Council 2023; (18) doi: 10.21518/ms2023-374
67
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study. Alzheimer's & Dementia 2024; 20(8) doi: 10.1002/alz.14033
68
Wenhua Bai, Zheng Zhu. Multiorgan crosstalk in MASLD/MASH: from hepatic pathogenesis to systemic complications. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1720780
69
Susana G. Rodrigues, Schalk van der Merwe, Aleksander Krag, Reiner Wiest. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases. Seminars in Immunology 2024; 71 doi: 10.1016/j.smim.2023.101859
70
Jie‐Lun Ku, Jia‐Rou Hsu, Yung‐Tsung Li, Li‐Ling Wu. Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review. Journal of Gastroenterology and Hepatology 2025; 40(1) doi: 10.1111/jgh.16750
71
Toon J.I. De Munck, Pauline Verhaegh, Corinne Spooren, Zlatan Mujagic, Tobias Wienhold, Daisy Jonkers, Ad A.M. Masclee, Ger H. Koek, Jef Verbeek. Colonic permeability is increased in non-cirrhotic patients with nonalcoholic fatty liver disease. Digestive and Liver Disease 2023; 55(5) doi: 10.1016/j.dld.2022.12.022
72
Shynggys Sergazy, Zarina Shulgau, Yevgeniy Kamyshanskiy, Zhaxybay Zhumadilov, Elena Krivyh, Alexander Gulyayev, Mohamad Aljofan. Blueberry and cranberry extracts mitigate CCL4-induced liver damage, suppressing liver fibrosis, inflammation and oxidative stress. Heliyon 2023; 9(4) doi: 10.1016/j.heliyon.2023.e15370
73
Francesca Romana Ponziani, Gaetano Coppola, Pierluigi Rio, Mario Caldarelli, Raffaele Borriello, Giovanni Gambassi, Antonio Gasbarrini, Rossella Cianci. Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go. Vaccines 2023; 11(10) doi: 10.3390/vaccines11101609
74
Syeda Tasnim Quayum, Nusrat Jahan Ikbal Esha, Siam Siraji, Sanaa S. Al Abbad, Zainab H.A. Alsunaidi, Mansour H. Almatarneh, Shofiur Rahman, Abdullah N. Alodhayb, Khuloud A. Alibrahim, Sarkar M.A. Kawsar, Kabir M. Uddin. Exploring the effectiveness of flavone derivatives for treating liver diseases: Utilizing DFT, molecular docking, and molecular dynamics techniques. MethodsX 2024; 12 doi: 10.1016/j.mex.2023.102537
75
Kanav Kaushal, Samagra Agarwal, Sanchit Sharma, Pooja Goswami, Namrata Singh, Vikas Sachdev, Shekhar Poudel, Prasenjit Das, Rajni Yadav, Dinesh Kumar, Gaurav Pandey, Deepak Gunjan, Anoop Saraya. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study. Journal of Clinical and Experimental Hepatology 2022; 12(4) doi: 10.1016/j.jceh.2022.01.006
76
Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD). Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2331460
77
Mohammad Al Hayek, Bisher Sawaf, Mohammed S. Beshr, Mulham Alom, Abdelaziz H. Salam, Mouaz Haffar, Rana H. Shembesh, Ahmad Kassem, Mohammed Abu-Rumaileh, Yusuf Hallak, Shahem Abbarh, Elias Batikh, Muhammed Elhadi, Monica Tincopa. Allopurinol Use Is Associated with Decreased Incidence of Hepatic Decompensation and Overall Mortality among Individuals with Cirrhosis: A Propensity-Matched Cohort Study. GE - Portuguese Journal of Gastroenterology 2025;  doi: 10.1159/000549923
78
Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of Clinical Medicine 2024; 13(3) doi: 10.3390/jcm13030919
79
Francesco Santopaolo, Gaetano Coppola, Lucia Giuli, Antonio Gasbarrini, Francesca Romana Ponziani. Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management. Microbiology Research 2022; 13(3) doi: 10.3390/microbiolres13030038
80
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1110536
81
Nasrin Mehranfard, Azadeh Yazdi, Asiye Rafiee Sardooi, Zeinab Shakerin, Maedeh Ghasemi. Honey protects against chronic unpredictable mild stress induced- intestinal barrier disintegration and hepatic inflammation. Molecular Biology Reports 2020; 47(11) doi: 10.1007/s11033-020-05888-4
82
Ludovico ABENAVOLI, Anna C. PROCOPIO, Emidio SCARPELLINI, Natale POLIMENI, Isabella AQUILA, Tiziana LARUSSA, Luigi BOCCUTO, Francesco LUZZA. Gut microbiota and non-alcoholic fatty liver disease. Minerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02896-5
83
Subhamay Adhikary, Akanksha Esmeeta, Amit Dey, Antara Banerjee, Biki Saha, Pournami Gopan, Asim K. Duttaroy, Surajit Pathak. Impacts of gut microbiota alteration on age-related chronic liver diseases. Digestive and Liver Disease 2024; 56(1) doi: 10.1016/j.dld.2023.06.017
84
Supriyo Ghosh, Amlan Jyoti Ghosh, Manab Deb Adhikari, Bipransh Kumar Tiwary, Tilak Saha. Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights. Journal of Diabetes & Metabolic Disorders 2026; 25(1) doi: 10.1007/s40200-026-01861-3
85
Lydia Giannitrapani, Marinella Ferraro, Aurelio Seidita, Anna Licata, Maurizio Soresi. Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption?. World Journal of Hepatology 2025; 17(12): 110076 doi: 10.4254/wjh.v17.i12.110076
86
Titilayo Olotu, Jessica M. Ferrell. Lactobacillus sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice. Microorganisms 2024; 12(12) doi: 10.3390/microorganisms12122488
87
Guole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun Li. Liver cirrhosis and complications from the perspective of dysbiosis. Frontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1320015
88
Shuang Gao, Muhammad Imran Khan, Fadia Kalsoom, Zhen Liu, Yanxin Chen, Zhengli Chen. Role of gene regulation and inter species interaction as a key factor in gut microbiota adaptation. Archives of Microbiology 2022; 204(6) doi: 10.1007/s00203-022-02935-5
89
Zishu Zhang, Heyun Tao, Kexin Mao, Fanying Meng, Shanghong Jiang, Junyi Chen, Xinmiao He, Xuefei Tian. The Central Qi theory in traditional Chinese medicine: Gut microbiota modulation as a strategic target for hepatocellular carcinoma therapy. Journal of Ethnopharmacology 2026; 360 doi: 10.1016/j.jep.2025.121147
90
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(5) doi: 10.1152/ajpgi.00161.2019
91
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?. World Journal of Clinical Cases 2021; 9(31): 9320-9332 doi: 10.12998/wjcc.v9.i31.9320
92
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00131
93
Suling Zeng, Bernd Schnabl. Roles for the mycobiome in liver disease. Liver International 2022; 42(4) doi: 10.1111/liv.15160
94
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng, Nguan Soon Tan. Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm. International Journal of Molecular Sciences 2022; 23(23) doi: 10.3390/ijms232314762
95
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen. Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes. Fibrosis 2024; 2(4) doi: 10.70322/fibrosis.2024.10006
96
Stefania Del Fabbro, Philip C. Calder, Caroline E. Childs. Microbiota-independent immunological effects of non-digestible oligosaccharides in the context of inflammatory bowel diseases. Proceedings of the Nutrition Society 2020; 79(4) doi: 10.1017/S0029665120006953
97
Fernando Vidal-Vanaclocha, Olatz Crende, Cira García de Durango, Alejandro Herreros-Pomares, Sandra López-Doménech, Álvaro González, Eva Ruiz-Casares, Thierry Vilboux, Riccardo Caruso, Hipólito Durán, Antonio Gil, Benedetto Ielpo, Fernando Lapuente, Yolanda Quijano, Emilio Vicente, Leticia Vidal-Lartitegui, Eduardo M. Sotomayor. Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes. Seminars in Cancer Biology 2021; 71 doi: 10.1016/j.semcancer.2020.08.001
98
Leonard Kaps, Carolina Medina-Montano, Matthias Bros, Stephan Grabbe, Simon Johannes Gairing, Eva M. Schleicher, Stephan Gehring, Jörn M. Schattenberg, Peter R. Galle, Marcus-Alexander Wörns, Michael Nagel, Christian Labenz, Tomasz Brzozowski. Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis. Mediators of Inflammation 2023; 2023 doi: 10.1155/2023/9930902
99
Mattia Paratore, Francesco Santopaolo, Giovanni Cammarota, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives. Journal of Clinical Medicine 2021; 10(12) doi: 10.3390/jcm10122605
100
Wanlin Hu, Yushen Wang, Junlei Han, Wenhong Zhang, Jun Chen, Xinyu Li, Li Wang. Microfluidic organ-on-a-chip models for the gut–liver axis: from structural mimicry to functional insights. Biomaterials Science 2025; 13(7) doi: 10.1039/D4BM01273A
101
Asmaa.F. Khafaga, Hassan A. Rudayni, Nourhan E. Khalifa, Abdullah S. Alawam, Ahmed A. Allam, Ayman E. Taha, Mohammed A.E. Naiel, Mohamed E. Abd El-Hack. The gut–liver axis in chronic liver diseases: An integrative immunopathological perspective bridging animal models and human evidence. Tissue and Cell 2026; 101 doi: 10.1016/j.tice.2026.103456
102
Li Zhang, Lei Feng, Lin Yang, Hao Wan. Noninvasive Detection and Monitoring of the Integrity of the Intestinal Barrier through NIR-II Fluorescence Imaging and Colorimetric Urinalysis. ACS Applied Materials & Interfaces 2025; 17(9) doi: 10.1021/acsami.4c20263
103
Tope Oyelade, Kevin P. Moore, Ali R. Mani. Physiological network approach to prognosis in cirrhosis: A shifting paradigm. Physiological Reports 2024; 12(13) doi: 10.14814/phy2.16133
104
Osamu Yoshino. Postinjury Multiple Organ Failure. Hot Topics in Acute Care Surgery and Trauma 2022;  doi: 10.1007/978-3-030-92241-2_13
105
Eamonn M. M. Quigley. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_8
106
Cheng Zhao, Xiaoming Kao, Zhiwei Wang, Qinjie Liu, Jie Wu, Qiongyuan Hu, Xiuwen Wu, Jianan Ren. Biomimetic enzyme barrier for preventing intestine-derived LPS induced diseases. RSC Advances 2020; 10(15) doi: 10.1039/C9RA08721D
107
Yifan Guo, Lin Chang, Ge Zhang, Zhanyan Gao, Hao Lin, Yuting Zhang, Liang Hu, She Chen, Bing Fan, Si Zhang, Ruyi Xue. The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance. Thrombosis Journal 2021; 19(1) doi: 10.1186/s12959-021-00282-x
108
Nicolás Ortiz-López, Catalina Fuenzalida, María Soledad Dufeu, Araceli Pinto-León, Alejandro Escobar, Jaime Poniachik, Juan Pablo Roblero, Lucía Valenzuela-Pérez, Caroll J. Beltrán. The immune response as a therapeutic target in non-alcoholic fatty liver disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.954869
109
Eptehal Mohammed Dongol, Fatma Rabea Ahmed Hamdan, Omyma Galal Ahmed, Rehab Hemdan Abdel-Aziz, Mahitab Younes, Rana Toghan Ahmed. Pathophysiological Mechanisms Linking Obstructive Sleep Apnea to Nonalcoholic Fatty Liver Disease. Sleep Medicine Research 2025; 16(2) doi: 10.17241/smr.2025.02859
110
Syeda Amrah Hashmi, Om Parkash, Asra tus Saleha Siddiqui. Malnutrition and liver disease in a developing country. World Journal of Gastroenterology 2021; 27(30): 4985-4998 doi: 10.3748/wjg.v27.i30.4985
111
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina Pervushova, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis. International Journal of Molecular Sciences 2024; 25(4) doi: 10.3390/ijms25041988
112
Vladimir Ivashkin, Evgenii Kozlov, Anna Levshina, Ekaterina Vasileva, Yana Letyagina, Andrey Suslov, Yury Zharikov, Elena Poluektova, Aliya Alieva, Roman Maslennikov. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
113
Jakub Rogalski, Joanna Grzelczyk, Aleksandra Margulska, Grzegorz Mirocha, Grażyna Budryn, Dominik Strzelecki, Oliwia Gawlik-Kotelnicka. I-FABP, citrulline and non-invasive liver dysfunction indices in patients with depression – cross-sectional study results. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-025-04559-7
114
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q.-H. Wang, Agostino Di Ciaula. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2021; 10(1) doi: 10.3390/biomedicines10010083
115
Roberta Forlano, Giordano Sigon. A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease. Digestive and Liver Disease 2023; 55(11) doi: 10.1016/j.dld.2023.07.029
116
Luoyi Zhu, Xin Zong, Xiao Xiao, Yuanzhi Cheng, Jie Fu, Zeqing Lu, Mingliang Jin, Fengqin Wang, Yizhen Wang. Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.773070
117
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
118
Kylynda C. Bauer, Paula T. Littlejohn, Victoria Ayala, Anna Creus-Cuadros, B. Brett Finlay. Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective. Gastroenterology 2022; 162(7) doi: 10.1053/j.gastro.2022.01.058
119
Roxana Liana Lucaciu, Sorina Cezara Coste, Adriana Corina Hangan, Mihaela Iancu, Olga Hilda Orășan, Angela Cozma, Sidonia Gog Bogdan, Lucia Maria Procopciuc. Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2025; 26(12) doi: 10.3390/ijms26125717
120
Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology 2022; 11(11) doi: 10.3390/biology11111622
121
Lucia Cerrito, Francesco Santopaolo, Flavia Monti, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Advances in pharmacotherapeutics for hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2021; 22(10) doi: 10.1080/14656566.2021.1892074
122
Daniel E. Di Zeo‐Sánchez, Irene Díaz‐Alberola, José María Pinazo‐Bandera, Miren García‐Cortés, Judith Sanabria‐Cabrera, Mercedes Robles‐Díaz, Ismael Álvarez‐Álvarez, M. Isabel Lucena, Raúl J. Andrade, Marina Villanueva‐Paz, Camilla Stephens. Intestinal permeability and immune‐inflammatory markers in patients with idiosyncratic drug‐induced liver injury, drug‐induced steatosis and metabolic dysfunction–associated steatotic liver disease (MASLD). British Journal of Pharmacology 2025; 182(21) doi: 10.1111/bph.70123
123
Zhiqiang Yan, Fang Yang, Zhu Hong, Shishun Wang, Zhang Jinjuan, Bing Han, Rujia Xie, Feiyun Leng, Qin Yang. Blueberry Attenuates Liver Fibrosis, Protects Intestinal Epithelial Barrier, and Maintains Gut Microbiota Homeostasis. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/5236149
124
Marc Micó-Carnero, Carlos Rojano-Alfonso, Ana Isabel Álvarez-Mercado, Jordi Gracia-Sancho, Araní Casillas-Ramírez, Carmen Peralta. Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery. International Journal of Molecular Sciences 2020; 22(1) doi: 10.3390/ijms22010044
125
Swadha Anand, Sharmila S. Mande. Host-microbiome interactions: Gut-Liver axis and its connection with other organs. npj Biofilms and Microbiomes 2022; 8(1) doi: 10.1038/s41522-022-00352-6
126
Roberta Forlano, Benjamin H. Mullish, Lauren A. Roberts, Mark R. Thursz, Pinelopi Manousou. The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(2) doi: 10.3390/ijms23020662
127
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, Giuseppe Celano, Maria De Angelis, Helen H. Wang, Domenica Maria Di Palo, Leonilde Bonfrate, David Q-H Wang, Piero Portincasa. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. Journal of Clinical Medicine 2020; 9(8) doi: 10.3390/jcm9082648
128
Yifei Zou, Xianjing Song, Ning Liu, Wei Sun, Bin Liu. Intestinal Flora: A Potential New Regulator of Cardiovascular Disease. Aging and disease 2022; 13(3) doi: 10.14336/AD.2021.1022
129
Reem Z. Sharaiha, Scott Shikora, Kevin P. White, Guilherme Macedo, Jim Toouli, Lillian Kow. Summarizing Consensus Guidelines on Obesity Management. Journal of Clinical Gastroenterology 2023; 57(10) doi: 10.1097/MCG.0000000000001916
130
A. S. Ostrovskaya, M. V. Maevskaya, K. M. Loban, M. S. Zharkova, M. P. Shapka, M. Yu. Nadinskaia, K. A. Gulyaeva, E. A. Vasiltsova, Yu. O. Chvileva, V. T. Ivashkin. Upper limb SMI for sarcopenia diagnosis in liver cirrhosis. Meditsinskiy sovet = Medical Council 2024; (15) doi: 10.21518/ms2024-382
131
Naila Shoaib, Zaman Khan, Marukh Ibrahim, Anjam Hafeez, Arooj Fatima, Hassan Imran, Fiza Saleem, Syed Muhammad Hassan Askari, Sidra Gull. Dyslipidemia and impaired liver function biomarkers in patients with hepatitis B liver cirrhosis. Journal of Taibah University Medical Sciences 2023; 18(4) doi: 10.1016/j.jtumed.2023.01.002
132
I. A. Krylova, A. V. Lyamin, V. I. Kupaev. Clinical improvement of some indicators of the activity of non-alcoholic fatty liver disease after correction of intestinal dysbiosis with dietary fiber. Experimental and Clinical Gastroenterology 2024; (2) doi: 10.31146/1682-8658-ecg-222-2-44-49
133
Huma Saeed, Luis Antonio Díaz, Antonio Gil-Gómez, Jeremy Burton, Jasmohan S. Bajaj, Manuel Romero-Gomez, Marco Arrese, Juan Pablo Arab, Mohammad Qasim Khan. Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology 2025; 31(Suppl) doi: 10.3350/cmh.2024.0811
134
Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial. World Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667
135
Domenica Maria Di Palo, Gabriella Garruti, Agostino Di Ciaula, Emilio Molina-Molina, Harshitha Shanmugam, Maria De Angelis, Piero Portincasa. Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis. Nutrients 2020; 12(2) doi: 10.3390/nu12020564
136
Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito. Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders. Antibiotics 2023; 12(6) doi: 10.3390/antibiotics12061068
137
Li Zhang, Zhiyi Zheng, Huanhuan Huang, Ya Fu, Tianbin Chen, Can Liu, Qiang Yi, Caorui Lin, Yongjun Zeng, Qishui Ou, Yongbin Zeng. Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2323236
138
Darrick K. Li, Snehal N. Chaudhari, Yoojin Lee, Mozhdeh Sojoodi, Arijit A. Adhikari, Lawrence Zukerberg, Stuti Shroff, Stephen Cole Barrett, Kenneth Tanabe, Raymond T. Chung, A. Sloan Devlin. Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury. Science Advances 2022; 8(34) doi: 10.1126/sciadv.abo2794
139
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease. Metabolites 2023; 13(6) doi: 10.3390/metabo13060772
140
Rahmawati MINHAJAT, Hanan AFIFAH, Husni CANGARA, Mirna MUIS, Agussalim BUKHARI, Sitti WAHYUNI. Beneficial effects of probiotic supplementation (<i>Lactiplantibacillus plantarum</i> Dad-13) on body weight, liver function, and liver histopathological features in non-alcoholic fatty liver disease (NAFLD) model Sprague-Dawley rats. Bioscience of Microbiota, Food and Health 2025; 44(4) doi: 10.12938/bmfh.2024-131
141
Marwa Matboli, Manar Fouad Ahmed, Amany Helmy Hasanin, Reham Hussein Mohamed, Eman H. Eltantawy, Ghada Galal Hamam, Marwa Ramadan M. Abdelhalim, Maryam Elmasry, Marwa M. El-Shafei, Shaimaa Hamady. Amlodipine and perindopril modulate miR-874-3p expression to regulate ferroptosis-linked LPCAT3/LACS4/GPX4 Axis and gut dysbiosis in metabolic-associated steatohepatitis. International Immunopharmacology 2025; 164 doi: 10.1016/j.intimp.2025.115333
142
Camila Marques de Alcântara Barreto, Eliane Almeida do Valle, Jessica Pronestino de Lima Moreira, Katia Farias e Silva, Siane Lopes Bittencourt Rosas, Patrícia Teixeira Santana, Ana Maria Pittella, Gustavo Pereira, Flavia Ferreira Fernandes, Renata de Mello Perez, Heitor Siffert Pereira de Souza. Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis. Annals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101567
143
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8) doi: 10.26442/00403660.2021.08.200917
144
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi. Oxidative Stress in Non-Alcoholic Fatty Liver Disease. Livers 2022; 2(1) doi: 10.3390/livers2010003
145
Montserrat Rodríguez-Ayala, Carolina Donat-Vargas, Belén Moreno-Franco, Diana María Mérida, José Ramón Banegas, Fernando Rodríguez-Artalejo, Pilar Guallar-Castillón. Association of a healthy beverage score with total mortality in the adult population of Spain: A nationwide cohort study. PLOS Medicine 2024; 21(1) doi: 10.1371/journal.pmed.1004337
146
Caterina Conte. Thyroid, Obesity and Metabolism. 2021;  doi: 10.1007/978-3-030-80267-7_7
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.